Category
Press Release
-
2026
-
Brighthouse Financial Announces Fourth Quarter and Full Year 2025 Results
-
Brighthouse Financial Announces Fourth Quarter and Full Year 2025 Results
-
AllianceBernstein Global High Income Fund, Inc. Releases Monthly Portfolio Update
-
Federal Realty Promotes Jeff Kreshek to Executive Vice President
-
Citizens Financial Group to Participate at the 2026 RBC Capital Markets Financial Institutions Conference
-
Citizens Financial Group to Participate at the 2026 RBC Capital Markets Financial Institutions Conference
-
ALLIANCEBERNSTEIN CLOSED-END FUNDS ANNOUNCE DISTRIBUTION RATES
-
AllianceBernstein National Municipal Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
-
ALLIANCEBERNSTEIN CLOSED-END FUNDS ANNOUNCE DISTRIBUTION RATES
-
Federal Realty Promotes Jeff Kreshek to Executive Vice President
-
ALLIANCEBERNSTEIN CLOSED-END FUNDS ANNOUNCE DISTRIBUTION RATES
-
METC Investors Have Opportunity to Lead Ramaco Resources, Inc. Securities Fraud Lawsuit
-
Ramaco Resources, Inc. (METC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
-
ComEd Reinforces Commitment to Fight Rising Energy Costs as Part of “The Exelon Promise”
-
BAE Systems demonstrates modular airborne electromagnetic attack capabilities at U.S. Air Force test events
-
Duke Energy Foundation commits $500,000 to support local environmental resilience programs across North Carolina
-
Duke Energy Foundation commits $500,000 to support local environmental resilience programs across North Carolina
-
Allstate to present at the Raymond James Institutional Investors Conference on March 2
-
Wells Fargo Names Dennis Devine to Lead Business Banking
-
Allstate to present at the Raymond James Institutional Investors Conference on March 2
-
AT&T Named America’s Best and Fastest Internet
-
Wells Fargo Names Dennis Devine to Lead Business Banking
-
AT&T Named America’s Best and Fastest Internet
-
Key4Women To Host Free Webinar Featuring “The Budgetnista” on Building Financial Confidence
-
UPDATE: Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million